Clover Health Investments, Corp (CLOV) is a publicly traded Healthcare sector company. As of July 18, 2026, CLOV trades at $4.59 with a market cap of $2.32B and a P/E ratio of 0.00. CLOV moved +4.89% today. Year to date, CLOV is +96.60%; over the trailing twelve months it is +53.49%. Its 52-week range spans $1.58 to $5.59. Analyst consensus is buy with an average price target of $4.48. Rallies surfaces CLOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover CLOV: 0 strong buy, 1 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $4.48.
| Metric | Value |
|---|---|
| Price | $4.59 |
| Market Cap | $2.32B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.59 |
| 52-Week Low | $1.58 |
| Volume | 4.64M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.21B |
| Net Income | $-56.94M |
| Gross Margin | 0.00% |
2 analysts cover CLOV: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.48.